Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-22-122556

Interim CEO & General Counsel bought 1,000 shares at $5.98 ($5,980)

From the SEC's structured data for this filing

Trades in this filing

Vogt Frederick G · Interim CEO & General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-28 Purchase : show line 1 in the form +1,000 $5.98 $5,980 2,000 D
Open-market purchases · 1,000 sh · avg $5.98 · $5,980
Loading xslF345X03/tm2231429-2_4seq1.xml…